3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Burkitt Lymphoma
12
Prostatic Neoplasms
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Plasmablastic Lymphoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Immunoblastic Lymphadenopathy
2
Enteropathy-Associated T-Cell Lymphoma
2
Neuroblastoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Hormone-Resistant Prostate Cancer
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HIV Infections
1
Composite Lymphoma
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Blast Crisis
1
Interventions
Vorinostat
2
Vincristine
2
Prednisone
2
Doxorubicin
2
Cyclophosphamide
2
siplizumab
1
pembrolizumab
1
liposomal doxorubicin
1
Rituximab
1
Etoposide
1
Bortezomib
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Subcutaneous panniculitis-like T-cell lymphoma
×
prednylidene
×
Clear all
No trials found.